HARBIN GLORIA PHARMACEUTICALS Co., LTD — Investor Relations & Filings
Harbin Gloria Pharmaceuticals Co., Ltd. focuses on the research, development, manufacturing, and commercialization of diverse pharmaceutical products. The company specializes in therapeutic areas including cardiovascular and cerebrovascular diseases, orthopedics, oncology, and metabolic disorders. Its portfolio comprises chemical drugs, biological products, and specialized injections, with key products such as Alprostadil and Deer Melon Polypeptide. The organization prioritizes technological innovation through a dedicated R&D infrastructure aimed at developing both generic and innovative medications. It maintains multiple production facilities and an extensive distribution network to supply healthcare solutions for chronic and acute conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2026年一季度业绩预增公告 | 2026-04-14 | Chinese | |
| 关于回购并注销离职人员已获授但尚未解除限售的限制性股票的公告 | 2025-12-29 | Chinese | |
| 2024年限制性股票激励计划之回购注销部分限制性股票事项的法律意见书 | 2025-12-29 | Chinese | |
| 独立董事提名人声明与承诺（徐宇虹） | 2025-12-29 | Chinese | |
| 第七届董事会第七次会议决议公告 | 2025-12-29 | Chinese | |
| 关于签署《广州誉衡生物科技有限公司之协议书》的进展公告 | 2025-12-08 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 34866857 | 2026年一季度业绩预增公告 | 2026-04-14 | Chinese | ||
|
2025
14 filings
| |||||
| 35839469 | 关于回购并注销离职人员已获授但尚未解除限售的限制性股票的公告 | 2025-12-29 | Chinese | ||
| 35839457 | 2024年限制性股票激励计划之回购注销部分限制性股票事项的法律意见书 | 2025-12-29 | Chinese | ||
| 35839403 | 独立董事提名人声明与承诺（徐宇虹） | 2025-12-29 | Chinese | ||
| 35839384 | 第七届董事会第七次会议决议公告 | 2025-12-29 | Chinese | ||
| 35839377 | 关于签署《广州誉衡生物科技有限公司之协议书》的进展公告 | 2025-12-08 | Chinese | ||
| 35839371 | 关于使用闲置自有资金进行委托理财的进展公告 | 2025-12-03 | Chinese | ||
| 35839355 | 关于董事、高级管理人员通过司法拍卖方式增持公司股份的自愿性披露公告 | 2025-11-21 | Chinese | ||
| 35839342 | 关于2024年限制性股票激励计划部分限制性股票回购注销完成的公告 | 2025-11-19 | Chinese | ||
| 35839330 | 关于签署《广州誉衡生物科技有限公司之协议书》的公告 | 2025-11-04 | Chinese | ||
| 35839316 | 2025年三季度报告 | 2025-10-28 | Chinese | ||
| 35839313 | 关于2024年限制性股票激励计划预留授予部分第一个限售期解除限售股份上市流通的提示性公告 | 2025-10-20 | Chinese | ||
| 35839302 | 第七届董事会第五次会议决议公告 | 2025-10-13 | Chinese | ||
| 35839288 | 关于2024年限制性股票激励计划之预留授予部分第一个限售期解除限售事宜的法律意见书 | 2025-10-13 | Chinese | ||
| 35839180 | 关于2024年限制性股票激励计划预留授予部分第一个限售期解除限售条件成就的公告 | 2025-10-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
HARBIN GLORIA PHARMACEUTICALS Co., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54476/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54476 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54476 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54476 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54476}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HARBIN GLORIA PHARMACEUTICALS Co., LTD (id: 54476)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.